NAGENASDAQ Capital Market·USD·Closed·Healthcare · Biotechnology
Niagen Bioscience Inc
$3.29+$0.08 · +2.49%day vs prior
Mkt Cap · USD
262.03M
P/E · TTM
16.9
Div Yield · ann
–
52-week
$2.87 – $10.52
at 5% of range
Niagen Bioscience Inc operates as a biotechnology enterprise with a core focus on promoting healthy aging. This company is also renowned for its pioneering research into nicotinamide adenine dinucleotide.